323 related articles for article (PubMed ID: 26124287)
1. Hypoactive sexual desire disorder: inventing a disease to sell low libido.
Meixel A; Yanchar E; Fugh-Berman A
J Med Ethics; 2015 Oct; 41(10):859-62. PubMed ID: 26124287
[TBL] [Abstract][Full Text] [Related]
2. Flibanserin: From Bench to Bedside.
Dooley EM; Miller MK; Clayton AH
Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
[TBL] [Abstract][Full Text] [Related]
3. Flibanserin and Female Sexual Desire.
Fantasia HC
Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
5. Flibanserin and its discontents.
Aftab A; Chen C; McBride J
Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
[TBL] [Abstract][Full Text] [Related]
6. Flibanserin for female sexual dysfunction.
Reviriego C
Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
[TBL] [Abstract][Full Text] [Related]
7. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Clayton AH; Dennerstein L; Pyke R; Sand M
Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
[TBL] [Abstract][Full Text] [Related]
8. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
Puppo G; Puppo V
Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
[No Abstract] [Full Text] [Related]
9. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
Thorp J; Palacios S; Symons J; Simon J; Barbour K
BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
[No Abstract] [Full Text] [Related]
10. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
11. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
Eldon AS; Giraldi A
Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
[TBL] [Abstract][Full Text] [Related]
12. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Holt H; Tingen J
Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
[No Abstract] [Full Text] [Related]
13. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
[No Abstract] [Full Text] [Related]
14. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
Gao Z; Yang D; Yu L; Cui Y
J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
[TBL] [Abstract][Full Text] [Related]
15. Margaret McCartney: Flibanserin for low sexual desire is not feminism.
McCartney M
BMJ; 2015 Oct; 351():h5650. PubMed ID: 26502743
[No Abstract] [Full Text] [Related]
16. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
[TBL] [Abstract][Full Text] [Related]
18. Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder.
Simon JA
Postgrad Med; 2010 Nov; 122(6):128-36. PubMed ID: 21084789
[TBL] [Abstract][Full Text] [Related]
19. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
[TBL] [Abstract][Full Text] [Related]
20. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
